Skip to main content

Table 4 Multivariate analysis of factors associated with overall survival in patients with Siewert type II/III AEG

From: Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data

Variable

Training cohort (n = 203)

Validation-1 cohort (n = 88)

Validation-2 cohort (n = 105)

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

P

Blood transfusion (vs. No)

1.260 (1.046–1.517)

0.015

NA

 

NA

 

Organ invasion (vs. Absence)

NA

 

2.124 (1.051–4.293)

0.036

NA

 

Serosal infiltration (vs. S0)

NA

 

NA

 

1.852 (1.287–2.667)

0.001

Borrmann type (vs. I)

NA

 

NA

 

NA

 

pTNM stage (vs. I-II)

1.438 (1.007–2.053)

0.046

NA

 

NA

 

Grade of differentiation (vs. Well)

NA

 

NA

 

NA

 

PLNa

NA

 

NA

 

NA

 

LNRa

NA

 

NA

 

NA

 

LODDSa

1.478 (1.322–1.651)

< 0.001

1.561 (1.237–1.970)

< 0.001

1.323 (1.079–1.623)

0.007

PLT (vs. < 229)

NA

 

0.400 (0.198–0.809)

0.011

NA

 

ALB (vs. < 39.4)

NA

 

NA

 

NA

 

CA-125 (vs. < 9.70)

NA

 

NA

 

NA

 
  1. Abbreviations: ALB albumin, CA125 cancer antigen 125, CI confidence interval, HR hazard ratio, LNR lymph node ratio, LODDS log odds of positive lymph node, NA not available, PLN positive lymph node, PLT platelet, pTNM pathological tumor node metastasis
  2. aContinuous variables